Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 4
Organic Process Research & Development · 18.11.2026
DOI: 10.1021/acs.oprd.6c00299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 18.11.2026. Verfasst von John S. Carey und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
In campaign 1, 97.75 kg of the orexin 1 receptor antagonist C4X3256 (1) was prepared in 3 stages from 2-methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8). In the first stage, the nitrile group was introduced using trimethylsilyl cyanide and benzoyl chloride. In the second stage, the nitrile was hydrolyzed to the carboxylic acid using aqueous NaOH and the acid isolated by crystallization as the hemidiisopropylethylamine salt. In the third stage, 6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridine-2-carboxylic acid (10) was coupled with the previously prepared amine (S)-2-(methylamino)-1-[5-(trifluoromethyl)-2-pyrazinylamino]propane hydrochloride salt (6) using T3P to produce C4X3256. In campaign 2, a combination of 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride and 2-hydroxypyridine N-oxide was used in place of T3P as the coupling agent to produce 293.5 kg of C4X3256 (1).
Zitieren
APA
Carey, J. S., Churchill, J. C., Firth, J. D., Knowles, A. R., & Leong, P. (2026). Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 4. Organic Process Research & Development. https://doi.org/10.1021/acs.oprd.6c00299
Vancouver
Carey JS, Churchill JC, Firth JD, Knowles AR, Leong P. Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 4. Organic Process Research & Development. 2026. doi:10.1021/acs.oprd.6c00299
BibTeX
@article{Carey2026,
author = {Carey, John S. and Churchill, Jonathan C. and Firth, James D. and Knowles, Andrew R. and Leong, Paul},
title = {Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 4},
journal = {Organic Process Research & Development},
year = {2026},
doi = {10.1021/acs.oprd.6c00299}
}
EUVIMED